Movicol Half

Macrogol 3350, the active ingredient in Movicol Half, is an osmotic laxative presented as a powder for oral solution for oral use. It is indicated for the treatment of constipation, faecal impaction, and for bowel preparation before diagnostic procedures in adult patients.

GNH USA supplies Movicol Half as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution, including temperature‑controlled shipping where required and comprehensive regulatory support for importers.

Movicol Half, an osmotic laxative, is used to manage conditions affecting bowel transit and stool consistency. - Constipation: softens stool and facilitates regular bowel movements in patients with chronic or acute constipation. - Faecal impaction: helps to break down hardened stool, allowing safe evacuation in cases of faecal impaction. - Bowel preparation for diagnostic procedures: provides effective bowel cleansing prior to colonoscopy or other gastrointestinal investigations.

Movicol Half may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Bloating: sensation of abdominal fullness. - Abdominal pain or cramps: mild to moderate discomfort. - Nausea: feeling of sickness. - Flatulence: increased intestinal gas. - Diarrhoea: loose stools occurring after dosing.

Serious or Rare Side Effects: - Severe dehydration: marked fluid loss requiring medical attention. - Electrolyte imbalance: abnormal sodium or potassium levels. - Allergic reaction: rash, itching, swelling, or difficulty breathing. - Severe abdominal pain: persistent or worsening pain. - Blood in stool: visible bleeding indicating possible mucosal injury.

Before prescribing Movicol Half, consider the following precautions to ensure safe and effective use. - Assess renal function: evaluate kidney status as impaired function may affect electrolyte handling. - Monitor electrolytes: check serum sodium and potassium levels during prolonged therapy. - Use caution in dehydration: avoid in patients with existing fluid loss without rehydration. - Avoid in intestinal obstruction: contraindicated where mechanical blockage is present. - Adjust dose in elderly: start with lower dose and titrate cautiously. - Store at ambient temperature: keep in original packaging, protect from moisture and heat.

Movicol Half can interact with other medicines; awareness of these interactions helps prevent adverse outcomes.

Major Interactions (Avoid): - Concomitant use with other osmotic laxatives: may cause excessive fluid loss and electrolyte disturbances. - Loop diuretics (e.g., furosemide): increased risk of hypokalaemia and dehydration. - Digoxin: electrolyte shifts can potentiate digoxin toxicity.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: monitor blood pressure and renal function due to volume changes. - NSAIDs: may affect renal perfusion, increasing risk of renal impairment. - Lithium: altered renal clearance may raise lithium levels.